Low expression of hepcidin and high expression of ferroportin were associated with a poor prognosis of patients, and the hepcidin expression level was associated with the pathological stage and vascular invasion in pancreatic cancer [70]. The gene discussed is HAMP; the disease is familial pancreatic carcinoma.